Daily Stock Analysis, BVX, Bovie Medical Corp, priceseries

Bovie Medical Corp. Daily Stock Analysis
Stock Information
Open
6.49
Close
6.48
High
6.71
Low
6.35
Previous Close
6.41
Daily Price Gain
0.07
YTD High
10.14
YTD High Date
Dec 27, 2006
YTD Low
0.34
YTD Low Date
Jul 15, 1999
YTD Price Change
5.78
YTD Gain
825.71%
52 Week High
7.70
52 Week High Date
Dec 11, 2018
52 Week Low
2.28
52 Week Low Date
Mar 12, 2018
52 Week Price Change
3.93
52 Week Gain
154.12%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jun 2. 2017
2.18
Jun 16. 2017
2.35
10 Trading Days
8.00%
Link
LONG
Sep 12. 2017
2.65
Oct 4. 2017
3.21
16 Trading Days
21.07%
Link
LONG
Apr 10. 2018
3.00
May 14. 2018
3.67
24 Trading Days
22.39%
Link
LONG
Jun 29. 2018
4.35
Jul 25. 2018
5.03
17 Trading Days
15.70%
Link
LONG
Aug 29. 2018
4.96
Sep 26. 2018
7.10
19 Trading Days
43.22%
Link
Company Information
Stock Symbol
BVX
Exchange
NYSE MKT
Company URL
http://www.boviemedical.com
Company Phone
800-537-2790
CEO
Robert L. Gershon
Headquarters
New York
Business Address
4 MANHATTANVILLE ROAD, SUITE 106, PURCHASE, NY 10577
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0000719135
About

Bovie Medical Corp. is an energy-based medical company, which engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Core, Original Equipment Manufacture, and J-Plasma. The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

Description

Bovie Medical Corporation, a medical device company, develops, manufactures, and markets electrosurgical devices and technologies, and related medical products used in doctor's offices, surgery centers, and hospitals worldwide. The company provides electrosurgical products, including desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during surgical procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue. It also offers electrosurgical disposables comprising Resistick II, a proprietary coating applied to stainless steel that resist eschar during surgery; and disposable laparoscopic electrodes for use by physicians in the areas of gynecology, general surgery, and urology. In addition, the company provides battery operated cauteries for precise hemostasis in ophthalmology; nerve locator stimulator primarily used for identifying motor nerves in hand and facial reconstructive surgery; penlights for use in physician offices; and specialty lighting instruments for use in ophthalmology, as well as distributes specialty lighting instruments for general surgery, hip replacement surgery, and endotracheal tubes placement. Further, it develops J-Plasma, a patented helium-based plasma surgical product, as well as designs, develops, and manufactures electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing agreements. Bovie Medical Corporation markets its products to distributors under own brands, such as Bovie, IDS, ICON, and DERM, as well as under a private label. The company was formerly known as An-Con Genetics Inc. and changed its name to Bovie Medical Corporation in October 1998. Bovie Medical Corporation was incorporated in 1982 and is headquartered in Purchase, New York.